SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...

In a challenging market environment, Hemispherx Biopharma Inc (NYSE:AIM), trading under the ticker AIM, has seen its stock price touch a 52-week low, reaching a sobering $0.13, marking an 82% decline ...

After back-to-back years of 20%-plus gains in 2023 and 2024, the S&P 500 is off to another strong start to 2025. However, the S&P 500's forward earnings multiple of 22 (as of Feb. 7) was also ...

Tesla stock is gaining ground following a recent report suggesting that the company could be on track to receive a $400 ...

Aircraft interiors, seats, components manufacturing, and maintenance. Read more about the company's acquisition by Bain ...

Shares of Elon Musk's Tesla electric car company have fallen sharply, leading some investors to wonder if the drop is related ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Following the company’s first quarter results, Haywood analyst Neal Gilmer has cut his price target on Organigram.

JPMorgan called Intel the "poster child" of US chip manufacturing and said that 2025 will be a "moment of truth" for the ...

We ran that screen on Feb. 15 last year, using data as of the market close the previous day. Nvidia's (NVDA) stock has returned 80% from Feb. 14, 2024, through Tuesday, while the S&P 500 SPX has ...

The Nifty index opened on a negative note, faced heavy selling pressure in the first half, but later witnessed recovery and ...

Nvidia stock is down 13% from its record high, as investors continue to digest the recent DeepSeek news out of China. Nvidia ...